Browsing by Author "Stojkovic, Stefan (58448712900)"
Now showing 1 - 7 of 7
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Accidental Sewing Pin Ingestion by a Tailor: A Case Report and Literature Review(2023) ;Stojkovic, Stefan (58448712900) ;Bjelakovic, Milica (14029809600) ;Stojkovic Lalosevic, Milica (57218133245) ;Stulic, Milos (55895099100) ;Pejic, Nina (57210712517) ;Radivojevic, Nemanja (57216412671) ;Stojkovic, Nemanja (58618429900) ;Martinov Nestorov, Jelena (16230832200)Culafic, Djordje (6603664463)Foreign body ingestion is a frequently encountered emergency in healthcare institutions. It mostly affects pediatric populations, although it can also affect adults with developmental delays, those with psychiatric diseases, drug abusers, and prisoners. Endoscopy is a diagnostic and treatment method for suspected foreign body ingestion. In this article, we discuss a 45-year-old tailor who swallowed a sewing pin while at work. The abdominal X-ray showed a needle-shaped metal shadow in the stomach region. During an upper endoscopy, it was discovered that a sewing pin with a sharp edge was stuck in the pylorus. The sewing pin was extracted endoscopically, and the patient was discharged the same day in good condition. Since the estimated risk of complications of foreign body ingestion in the adult population is about 35%, and the most common complications include impaction, laceration, bleeding, or perforation of the gastrointestinal wall, endoscopic or surgical removal is necessary. This also emphasizes the importance of a careful endoscopic evaluation of some at-risk occupations for foreign body ingestion with or without gastrointestinal complaints. © 2023 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Correlation between Radiological Characteristics, PET-CT and Histological Subtypes of Primary Lung Adenocarcinoma—A 102 Case Series Analysis(2024) ;Colic, Nikola (57201737908) ;Stevic, Ruza (24823286600) ;Stjepanovic, Mihailo (55052044500) ;Savić, Milan (24830640100) ;Jankovic, Jelena (57211575577) ;Belic, Slobodan (57222640039) ;Petrovic, Jelena (57207943674) ;Bogosavljevic, Nikola (57211279852) ;Aleksandric, Dejan (58556662500) ;Lukic, Katarina (59004030300) ;Kostić, Marko (57194713012) ;Saponjski, Dusan (57193090494) ;Vasic Madzarevic, Jelena (59003973000) ;Stojkovic, Stefan (58448712900) ;Ercegovac, Maja (24821301800)Garabinovic, Zeljko (56323581600)Background and Objectives: Lung cancer is the second most common form of cancer in the world for both men and women as well as the most common cause of cancer-related deaths worldwide. The aim of this study is to summarize the radiological characteristics between primary lung adenocarcinoma subtypes and to correlate them with FDG uptake on PET-CT. Materials and Methods: This retrospective study included 102 patients with pathohistologically confirmed lung adenocarcinoma. A PET-CT examination was performed on some of the patients and the values of SUVmax were also correlated with the histological and morphological characteristics of the masses in the lungs. Results: The results of this analysis showed that the mean size of AIS-MIA (adenocarcinoma in situ and minimally invasive adenocarcinoma) cancer was significantly lower than for all other cancer types, while the mean size of the acinar cancer was smaller than in the solid type of cancer. Metastases were significantly more frequent in solid adenocarcinoma than in acinar, lepidic, and AIS-MIA cancer subtypes. The maximum standardized FDG uptake was significantly lower in AIS-MIA than in all other cancer types and in the acinar predominant subtype compared to solid cancer. Papillary predominant adenocarcinoma had higher odds of developing contralateral lymph node involvement compared to other types. Solid adenocarcinoma was associated with higher odds of having metastases and with higher SUVmax. AIS-MIA was associated with lower odds of one unit increase in tumor size and ipsilateral lymph node involvement. Conclusions: The correlation between histopathological and radiological findings is crucial for accurate diagnosis and staging. By integrating both sets of data, clinicians can enhance diagnostic accuracy and determine the optimal treatment plan. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Genetic Determinants of Clarithromycin and Fluoroquinolones Resistance in Helicobacter pylori in Serbia(2024) ;Kekic, Dusan (36696225200) ;Jovicevic, Milos (57223044336) ;Kabic, Jovana (57215669275) ;Lolic, Iva (57424315300) ;Gajic, Ina (55428924700) ;Stojkovic, Stefan (58448712900) ;Ranin, Lazar (6602522806) ;Milosavljevic, Tomica (7003788952) ;Opavski, Natasa (6507364674) ;Rankovic, Ivan (57192091879)Milivojevic, Vladimir (57192082297)Background/Objectives: Stomach infections by Helicobacter pylori can cause acute or chronic gastritis, peptic ulcers, and gastric cancer. The rise in antibiotic resistance is a significant health issue highlighted by the World Health Organization. The increasing number of treatment failures underscores the necessity for antibiotic susceptibility testing (AST). The study aimed to investigate the current prevalence and resistance to fluoroquinolones and clarithromycin with their detected mutations. Methods: Stomach biopsies from symptomatic patients were subjected to molecular testing by GenoType Helico DR kit (Hain Lifescience GmbH, Nehren, Germany). Results: Positive findings on the presence of H. pylori were detected in 42.4% of symptomatic patients, with the significant majority of patients (69%) having previously failed treatments. The resistance rates to fluoroquinolones and clarithromycin were 53.9% and 58.5%, respectively, with significantly higher rates in secondary resistant strains. The main resistance markers in fluoroquinolones and clarithromycin were N87K (27.4%) and A2147G (78.6%), respectively. Hetero-resistance or mixed genotypes were detected in over 20% of tested patients. During the study period, a significant increase in trends in both fluoroquinolones and clarithromycin resistance rates was observed. Conclusions: Results indicate the need for the implementation of the latest Maastricht VI Consensus recommendations for both AST whenever possible and the use of tailored guided therapy options due to high resistance rates and possible treatment failures. The GenoType Helico DR kit is a useful tool for AST, especially in cases of mixed H. pylori genotypes. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Genetic Determinants of Clarithromycin and Fluoroquinolones Resistance in Helicobacter pylori in Serbia(2024) ;Kekic, Dusan (36696225200) ;Jovicevic, Milos (57223044336) ;Kabic, Jovana (57215669275) ;Lolic, Iva (57424315300) ;Gajic, Ina (55428924700) ;Stojkovic, Stefan (58448712900) ;Ranin, Lazar (6602522806) ;Milosavljevic, Tomica (7003788952) ;Opavski, Natasa (6507364674) ;Rankovic, Ivan (57192091879)Milivojevic, Vladimir (57192082297)Background/Objectives: Stomach infections by Helicobacter pylori can cause acute or chronic gastritis, peptic ulcers, and gastric cancer. The rise in antibiotic resistance is a significant health issue highlighted by the World Health Organization. The increasing number of treatment failures underscores the necessity for antibiotic susceptibility testing (AST). The study aimed to investigate the current prevalence and resistance to fluoroquinolones and clarithromycin with their detected mutations. Methods: Stomach biopsies from symptomatic patients were subjected to molecular testing by GenoType Helico DR kit (Hain Lifescience GmbH, Nehren, Germany). Results: Positive findings on the presence of H. pylori were detected in 42.4% of symptomatic patients, with the significant majority of patients (69%) having previously failed treatments. The resistance rates to fluoroquinolones and clarithromycin were 53.9% and 58.5%, respectively, with significantly higher rates in secondary resistant strains. The main resistance markers in fluoroquinolones and clarithromycin were N87K (27.4%) and A2147G (78.6%), respectively. Hetero-resistance or mixed genotypes were detected in over 20% of tested patients. During the study period, a significant increase in trends in both fluoroquinolones and clarithromycin resistance rates was observed. Conclusions: Results indicate the need for the implementation of the latest Maastricht VI Consensus recommendations for both AST whenever possible and the use of tailored guided therapy options due to high resistance rates and possible treatment failures. The GenoType Helico DR kit is a useful tool for AST, especially in cases of mixed H. pylori genotypes. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Hepcidin is a reliable marker of iron deficiency anemia in newly diagnosed patients with inflammatory bowel disease(2020) ;Lalosevic, Milica Stojkovic (57218133245) ;Toncev, Ljubisa (56023913400) ;Stankovic, Sanja (7005216636) ;Dragasevic, Sanja (56505490700) ;Stojkovic, Stefan (58448712900) ;Jovicic, Ivana (55672227100) ;Stulic, Milos (55895099100) ;Culafic, Djordje (6603664463) ;Milovanovic, Tamara (55695651200) ;Stojanovic, Marija (57218666738) ;Aleksic, Marko (57211851267) ;Stjepanovic, Mihailo (55052044500) ;Lalosevic, Jovan (57190969635) ;Kiurski, Stanimir (57220806455) ;Oluic, Branislav (57201078229) ;Markovic, Aleksandra Pavlovic (24438035400)Stojkovic, Mirjana (58776160500)Background and Aim. Differentiating iron deficiency anemia (IDA) from anemia of chronic disease (ACD) in patients with inflammatory bowel disease (IBD) represents a clinical challenge. Hepcidin is a polypeptide synthetized in the liver, and iron levels or inflammation mostly regulate hepcidin production. Our aim was to determine serum hepcidin levels in patients with inflammatory bowel disease (IBD) as well to investigate whether hepcidin levels correlate with disease activity. Material and Methods. A case-control study was preformed among newly diagnosed IBD patients and same number age- and sex-matched healthy controls. All patients underwent a total ileocolonoscopy. Complete blood count was obtained in addition to inflammatory markers (CRP, erythrocyte sedimentation rate-ESR). Serum levels of hepcidin were determined with commercially available enzyme-linked immunosorbent assay (DRG Instruments Marburg, Germany). Serum iron, TIBC, and UIBC were assessed with an electrochemiluminesence immunoassay, and soluble transferrin receptor (sTfR) was assessed using an immunoturbidimetric method. Mayo score and CDAI, respectively, were calculated for each patient. Statistical analyses were performed using the SPSS software version 20.0 for Windows. Results. There was a high statistically significant difference between IBD patients and controls in levels of hepcidin (P < 0:01). Namely, serum hepcidin levels were significantly higher in the control group. There was no statistically significant correlation of serum hepcidin with CRP, Mayo score, or CDAI, respectively (P > 0:05). However, we have found a statistically significant negative correlation of sTfR and TIBC with hepcidin (P < 0:01). Conclusion. Results of our study suggest that hepcidin is a reliable marker of IDA in patients with IBD, and it could be used in routine clinical practice when determining adequate therapy in these patients. Copyright © 2020 Stojkovic Lalosevic Milica et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Some of the metrics are blocked by yourconsent settings
Publication Hepcidin is a reliable marker of iron deficiency anemia in newly diagnosed patients with inflammatory bowel disease(2020) ;Lalosevic, Milica Stojkovic (57218133245) ;Toncev, Ljubisa (56023913400) ;Stankovic, Sanja (7005216636) ;Dragasevic, Sanja (56505490700) ;Stojkovic, Stefan (58448712900) ;Jovicic, Ivana (55672227100) ;Stulic, Milos (55895099100) ;Culafic, Djordje (6603664463) ;Milovanovic, Tamara (55695651200) ;Stojanovic, Marija (57218666738) ;Aleksic, Marko (57211851267) ;Stjepanovic, Mihailo (55052044500) ;Lalosevic, Jovan (57190969635) ;Kiurski, Stanimir (57220806455) ;Oluic, Branislav (57201078229) ;Markovic, Aleksandra Pavlovic (24438035400)Stojkovic, Mirjana (58776160500)Background and Aim. Differentiating iron deficiency anemia (IDA) from anemia of chronic disease (ACD) in patients with inflammatory bowel disease (IBD) represents a clinical challenge. Hepcidin is a polypeptide synthetized in the liver, and iron levels or inflammation mostly regulate hepcidin production. Our aim was to determine serum hepcidin levels in patients with inflammatory bowel disease (IBD) as well to investigate whether hepcidin levels correlate with disease activity. Material and Methods. A case-control study was preformed among newly diagnosed IBD patients and same number age- and sex-matched healthy controls. All patients underwent a total ileocolonoscopy. Complete blood count was obtained in addition to inflammatory markers (CRP, erythrocyte sedimentation rate-ESR). Serum levels of hepcidin were determined with commercially available enzyme-linked immunosorbent assay (DRG Instruments Marburg, Germany). Serum iron, TIBC, and UIBC were assessed with an electrochemiluminesence immunoassay, and soluble transferrin receptor (sTfR) was assessed using an immunoturbidimetric method. Mayo score and CDAI, respectively, were calculated for each patient. Statistical analyses were performed using the SPSS software version 20.0 for Windows. Results. There was a high statistically significant difference between IBD patients and controls in levels of hepcidin (P < 0:01). Namely, serum hepcidin levels were significantly higher in the control group. There was no statistically significant correlation of serum hepcidin with CRP, Mayo score, or CDAI, respectively (P > 0:05). However, we have found a statistically significant negative correlation of sTfR and TIBC with hepcidin (P < 0:01). Conclusion. Results of our study suggest that hepcidin is a reliable marker of IDA in patients with IBD, and it could be used in routine clinical practice when determining adequate therapy in these patients. Copyright © 2020 Stojkovic Lalosevic Milica et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Some of the metrics are blocked by yourconsent settings
Publication Prognostic value of serum 25-hydroxyvitamin D levels and malnutrition status on postoperative complications in patients following laryngectomy with neck dissection(2025) ;Radivojevic, Nemanja (57216412671) ;Grujicic, Sandra Sipetic (56676073300) ;Suljagic, Vesna (6506075339) ;Stojkovic, Stefan (58448712900) ;Arsovic, Konstantin (58782102600) ;Jakovljevic, Sasa (57455265100) ;Bukurov, Bojana (55605047500)Arsovic, Nenad (17033449500)Background: Postoperative complications (PCs) following total laryngectomy remain a significant challenge, with recent investigations directed toward the impact of nutrition status and vitamin D deficiency. Objectives: To elucidate the association between preoperative vitamin D level status, malnutrition risk score, and surgical and survival outcomes in patients with advanced laryngeal cancer following total laryngectomy. Study design: Prospective cohort study. Methods: Sixty-four patients with advanced laryngeal carcinoma treated with total laryngectomy were included in the study. Serum levels of 25(OH) D3 were measured employing a commercial chemiluminescent immunoassay kit, while nutrition status was evaluated using the nutrition risk index (NRI) and Malnutrition universal screening tool (MUST). Results: The mean serum 25(OH) D level was 37.1 ± 19.4 nmol/L (range 11.0-100.6 nmol/L), with 47% of patients exhibiting vitamin D deficiency and 31% displaying insufficiency. Medium/high MUST score had 53% of patients, and moderate/severe NRI was verified in 48% of patients. Univariate logistic regression analysis identified MUST score, GPS score, neutrophil-to-lymphocyte ratio, and circulating 25(OH) D levels as predictive for the occurrence of PCs. In multivariate analysis, MUST score and circulating 25(OH) D levels remained significantly associated with PCs. Patients with high nutrition risk had significantly lower two-year OS rates compared to the medium and low nutrition risk groups, respectively (30% vs. 62% and 83%, p = 0.010). Conclusion: Early identification of malnourished or patients with vitamin D deficiency and those who would benefit from specific nutritional support could be beneficial for minimizing the risk of development of surgical complications and help improve our clinical outcomes. © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024.
